GP explains four type 2 diabetes treatments — new one could be on NHS soon

Children over 10 years old and adults over 18 with type 2 diabetes can take metformin, according to Diabetes UK. Metformin is ...

Weight Loss Drugs Are Quietly Transforming the Economy in Unexpected Ways

Weight loss drugs like GLP-1s are changing consumer spending habits, affecting sectors from dining to retail and travel across the economy.
Everyday Health on MSN

Retatrutide Delivered Weight Loss Results on Par With Surgery in a New Obesity Trial

The latest clinical trial results for retatrutide suggest this experimental drug could help adults with obesity shed more ...
Scientific American

Trial results of next-gen weight-loss drug retatrutide bring it one step closer to FDA approval

While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three ...

A New Weight-Loss Drug Just Outperformed Popular GLP-1s. Here’s What It Means for the Future of Health

Retatrutide, Eli Lilly's new experimental drug, helped some participants lose up to 28 percent of their body weight in ...

PCOS Gets a New Name After Decades of Confusion—Here’s What It Means for Fertility

Eighty-six percent of surveyed patients and 71% of clinicians supported the new name, according to the consensus published in ...
CNET

Samsung Messages Is Being Retired. Here's How to Move Everything Before July

The end of Samsung Messages is no longer a rumor or a distant possibility; it's a July 2026 deadline that's now weeks away. Samsung began nudging Galaxy users toward Google Messages back in 2024, when ...

Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy

Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Zepbound and Wegovy.